VanEck launches genomics and healthcare innovators ETF

Targets genomics and digitalisation

VanEck has launched a genomics and healthcare innovators ETF, offering investors access to a range of companies across these themes.

The VanEck Genomics and Healthcare Innovators UCITS ETF, launched today (7 September) on London Stock Exchange and Deutsche Börse Xetra, will provide investors with exposure to companies operating across genomics and digitalisation, genomics companies being those examining the interaction between genes and gene products. Martijn Rozemuller, CEO at VanEck Europe, explained that genetic treatments, while once considered experimental and expensive, were becoming more affordable and common and that although the genomics industry was still in early stages, the space offered potential growth o...